BioCorRx Completes $2.25 Million Private Placement

ANAHEIM, CA, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that the Company completed a private placement, whereby it issued 1.125 million common stock shares at a price of $2.00 per share, for total proceeds of $2.25 million. The private placement was done with Louis Lucido and Joseph Galligan, both members of the Company’s Board of Directors.

Click to view original post